Compare
Doximity vs Omnicell (DOCS vs OMCL)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Doximity (DOCS) returned -49.2% and Omnicell (OMCL) +4.5%; so far this year the figures are -26.6% and -17.6%.
Doximity is the larger company by market value, about 3.4 times the size of Omnicell.
On trailing earnings, DOCS trades at 45.2 times and OMCL at 38.9 times.
Revenue grew +6.5% at DOCS and +5.6% at OMCL over the last year.
Data as of the latest close. Not investment advice.
Relative performance
| DOCS | OMCL | |
|---|---|---|
| Price | $32.51 | $37.34 |
| 1-day | -2.02% | -1.81% |
| YTD | -26.58% | -17.57% |
| 1 year | -49.20% | +4.48% |
| 3 years | +59.91% | +4.39% |
| Market cap | $5.8B | $1.7B |
| P/E | 45.2 | 38.9 |
| P/S | 8.76 | 1.38 |
| P/B | 6.24 | 1.30 |
| Revenue growth | +6.50% | +5.60% |
| EPS growth | -42.90% | +123.30% |
| Gross margin % | 86.8 | 45.1 |
| Net margin % | 21.1 | 3.6 |
| ROE % | 15.0 | 3.4 |
| Debt / equity | 0.00 | 0.00 |
| FCF yield % | 5.3 | 8.5 |
| Dividend yield % | — | — |
| Beta | 0.57 | 1.13 |
| RSI (14) | 54.9 | 54.7 |
| Technical rating |